Table 5. Comparison of plasma amino acids concentration (nmol/mL) between control, DM-cont, and DM-empa after 12 week treatment period.
Control (n = 12) | DM-cont (n = 16) | DM-empa (n = 5) | |
---|---|---|---|
proline | 66.8±4.2 | 63.6±4.3 | 85.6±11.4 |
sarcosine | 2.8±0.3 | 3.4±0.3 | 4.2±0.5* |
glycine | 107.3±8.6 | 107.6±7.7 | 162.0±16.8*# |
glutamine | 662.8±49.6 | 466.5±61.5* | 400.7±37.8 |
ornithine | 51.9±5.9 | 34.6±4.2* | 31.4±4.2 |
tryptophan | 47.3±2.9 | 37.8±3.5 | 31.0±2.9* |
α-aminobutyric acid | 7.6±1.1 | 5.7±0.3* | 5.0±0.1*# |
alanine | 271.2±18.2 | 326.1±18.9 | 246.0±6.8 |
valine | 96.7±6.4 | 134.9±10.5* | 84.5±10.9# |
isoleucine | 34.9±2.2 | 46.1±3.7* | 28.5±3.3# |
Plasma concentration of amino acids showing VIP values ≥ 1. Data were represented as mean ± SE.
* p<0.05 vs control.
# p<0.05 vs DM-cont.